CL2007003162A1 - USE OF COMPOUNDS DERIVED FROM VITAMIN D TO PREVENT, TREAT OR DAMAGE A HYPERPROLIFERATIVE DISORDER. - Google Patents

USE OF COMPOUNDS DERIVED FROM VITAMIN D TO PREVENT, TREAT OR DAMAGE A HYPERPROLIFERATIVE DISORDER.

Info

Publication number
CL2007003162A1
CL2007003162A1 CL200703162A CL2007003162A CL2007003162A1 CL 2007003162 A1 CL2007003162 A1 CL 2007003162A1 CL 200703162 A CL200703162 A CL 200703162A CL 2007003162 A CL2007003162 A CL 2007003162A CL 2007003162 A1 CL2007003162 A1 CL 2007003162A1
Authority
CL
Chile
Prior art keywords
vitamin
treat
damage
prevent
compounds derived
Prior art date
Application number
CL200703162A
Other languages
Spanish (es)
Inventor
John G Curd
Original Assignee
Novacea Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacea Inc filed Critical Novacea Inc
Publication of CL2007003162A1 publication Critical patent/CL2007003162A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL200703162A 2006-11-01 2007-10-31 USE OF COMPOUNDS DERIVED FROM VITAMIN D TO PREVENT, TREAT OR DAMAGE A HYPERPROLIFERATIVE DISORDER. CL2007003162A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86390906P 2006-11-01 2006-11-01
US96816007P 2007-08-27 2007-08-27

Publications (1)

Publication Number Publication Date
CL2007003162A1 true CL2007003162A1 (en) 2008-05-30

Family

ID=39365038

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703162A CL2007003162A1 (en) 2006-11-01 2007-10-31 USE OF COMPOUNDS DERIVED FROM VITAMIN D TO PREVENT, TREAT OR DAMAGE A HYPERPROLIFERATIVE DISORDER.

Country Status (3)

Country Link
CL (1) CL2007003162A1 (en)
TW (1) TW200833345A (en)
WO (1) WO2008057363A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110152207A1 (en) * 2009-12-23 2011-06-23 Goff Jesse P Use of vitamin d glycosides and sulfates for treatment of disease
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
EP2988752A4 (en) 2013-04-24 2017-01-18 Salk Institute for Biological Studies Vitamin d receptor/smad genomic circuit gates fibrotic response
AU2014274864B2 (en) 2013-06-05 2018-10-18 Salk Institute For Biological Studies Vitamin D receptor agonists to treat diseases involving CXCL12 activity
WO2019023149A1 (en) 2017-07-24 2019-01-31 Salk Institute For Biological Studies Use of bromodomain-containing protein 9 antagonists in combination with vitamin d receptor agonists in diabetes treatment
AU2021212659A1 (en) 2020-01-28 2022-08-04 Reflexion Medical, Inc. Joint optimization of radionuclide and external beam radiotherapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
CA2326117A1 (en) * 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
CN1561218A (en) * 2001-07-27 2005-01-05 努特里奇亚有限公司 Enteral compositions for the prevention and/or treatment of sepsis
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
WO2006036892A2 (en) * 2004-09-24 2006-04-06 Sapphire Therapeutics, Inc. Use of inhibitors of 24-hydroxylase in the treatment of cancer

Also Published As

Publication number Publication date
WO2008057363A3 (en) 2008-08-14
WO2008057363A2 (en) 2008-05-15
TW200833345A (en) 2008-08-16

Similar Documents

Publication Publication Date Title
BRPI0922475A2 (en) compound, pharmaceutical composition, method for treating cancer, and use of a compound.
BRPI0923325A2 (en) methods for using a compound, and for suppressing the production of a free isocyanate compound.
CL2008000754A1 (en) COMPOUND DERIVED FROM NITROGEN HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE TO TREAT CANCER AND HYPERPROLIFERATIVE DISORDERS.
BRPI0815717A2 (en) IMIDAZYPIRAZINE COMPOUNDS.
BRPI1008498A2 (en) Compound, compound prodrug, medicament, and use of a compound.
CR10353A (en) NEW COMPOUNDS.
ATE513831T1 (en) PYRIDINÄ3,4-BÜPYRAZINONE
NL2000527A1 (en) Dibenzylamine compounds and derivatives.
BRPI0908100A2 (en) Combination product, use of a compound, and method of treating cancer
BRPI0813670A2 (en) TREATMENT COMPOUNDS
BRPI0813438A2 (en) PROCESS TO PREPARE A COMPOUND, USE OF A COMPOUND, AND COMPOUND.
BRPI1014691A2 (en) Compound, and process for the preparation of a compound.
CL2007003162A1 (en) USE OF COMPOUNDS DERIVED FROM VITAMIN D TO PREVENT, TREAT OR DAMAGE A HYPERPROLIFERATIVE DISORDER.
BRPI0718324A2 (en) METHODS FOR TREATING DEPRESSION.
BRPI0917147A2 (en) compound or salt thereof, use of a compound or salt thereof, and process for making a compound.
ES1059722Y (en) ROPE FOR INDIVIDUAL PROTECTION ELEMENTS.
BRPI0916847A2 (en) solid preparation, and methods for stabilizing a compound and for improving the dissolution property of a compound.
BRPI0914248A2 (en) Processes for the hydrogenolysis of a furfuryl derivative and for the preparation of a 2-methylfuran derivative.
CL2008000093A1 (en) COMPOUNDS DERIVED FROM PIRIDINA, INHIBITORS OF P2Y12; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF A PLAQUETARY AGREGATION DISORDER.
BRPI0818422A2 (en) Process for the preparation of melamine.
BRPI0814581A2 (en) process for the preparation of a compound, and, compound.
BRPI0807853A2 (en) CLOTHING FOR CLOTHING.
NL2000514A1 (en) Dibenzylamine compounds and derivatives.
BRPI0913586A2 (en) combination, use of combination, method of treating, inhibiting or preventing a disease or condition.
BRPI0819653A2 (en) METHOD FOR THE PRODUCTION OF A TETRAPIRROL COMPOUND, AND, TETRAPIRROL COMPOUND.